Tapewire

Nasdaq · USD

LIF

Life360, Inc.

Export transactions ↓
Tapewire entity
1972
SEC CIK
0001581760
Parsed reports
308

Last 12 months

Inside the activity.

0 purchase rows · 66 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202509
Dec 2025013
Jan 202601
Feb 202601
Mar 202606
Apr 202604
May 202604
Jun 202605
Jul 202604
Aug 2026011
Sep 202604
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 26, 2026 Filed Mar 27, 2026 23:54 UTC
Haro AlexDirector
Exercise / conversionStock Option (right to buy) · Derivative 3,170 $0.00 Strike: $8.19 $0.00
Disclosure

SEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 5

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,729

Underlying: Common stock · 3,170 shares

Expires 2028-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 23:54 UTC
Haro AlexDirector
Exercise / conversionStock Option (right to buy) · Derivative 125,391 $0.00 Strike: $2.15 $0.00
Disclosure

SEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 4

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 125,391 shares

Expires 2027-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 23:54 UTC
Haro AlexDirector
Exercise / conversionCommon stock 15,972 $13.35 $213,226.20
Disclosure

SEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 3

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,005,848

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 23:54 UTC
Haro AlexDirector
Exercise / conversionCommon stock 3,170 $8.19 $25,962.30
Disclosure

SEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 2

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 989,876

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 23:54 UTC
Haro AlexDirector
Exercise / conversionCommon stock 125,391 $2.15 $269,590.65
Disclosure

SEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 1

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 986,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 22:50 UTC
Antonoff LaurenDirector · Chief Executive Officer
GrantCommon Stock 24,265 $0.00 $0.00
Disclosure

SEC source: 0001581760-26-000040 · wk-form4_1774651801.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,497

F1 · kind: Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on April 9, 2025. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 25, 2026, it was determined that the performance metric had been met. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the PRSUs vested on January 1, 2026 with the remaining 75% converting to time-based RSUs and vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest dat

F2 · balance_after: Includes 167,632 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 22:55 UTC
Hulls ChrisDirector
GrantCommon Stock 54,595 $0.00 $0.00
Disclosure

SEC source: 0001581760-26-000042 · wk-form4_1774652116.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,914

F1 · kind: Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on April 9, 2025. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 25, 2026, it was determined that the performance metric had been met. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the PRSUs vested on January 1, 2026 with the remaining 75% converting to time-based RSUs and vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest date.

F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes 162,966 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 23:53 UTC
Burke Russell JohnChief Financial Officer
GrantCommon stock 24,265 $0.00 $0.00
Disclosure

SEC source: 0001581760-26-000045 · wk-form4_1774655597.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,838

F1 · kind: Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on April 9, 2025. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 25, 2026, it was determined that the performance metric had been met. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the PRSUs vested on January 1, 2026 with the remaining 75% converting to time-based RSUs and vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest date.

F2 · balance_after: Includes 80,838 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 22:19 UTC
Hulls ChrisDirector
Exercise / conversionStock Option (right to buy) · Derivative 27,000 $0.00 Strike: $8.19 $0.00
Disclosure

SEC source: 0001581760-26-000038 · wk-form4_1774304360.xml · derivative · entry 6

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,801

Underlying: Common stock · 27,000 shares

Expires 2028-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F6 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 22:19 UTC
Hulls ChrisDirector
SaleCommon Stock 15,133 $39.43 $596,694.19
Disclosure

SEC source: 0001581760-26-000038 · wk-form4_1774304360.xml · nonDerivative · entry 2

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,319

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.23 to $39.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 22:19 UTC
Hulls ChrisDirector
Exercise / conversionCommon Stock 27,000 $8.19 $221,130.00
Disclosure

SEC source: 0001581760-26-000038 · wk-form4_1774304360.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 349,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 22:55 UTC
Synge JamesDirector
GiftCommon stock 8,333 $0.00 $0.00
Disclosure

SEC source: 0001581760-26-000036 · wk-form4_1773960942.xml · nonDerivative · entry 1

Synge James · CIK 0001932661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,421

F1 · kind: This transaction reflects a bona fide gift of the Issuer's stock for charitable purposes.

F2 · shares: Represents shares of the Issuer's common stock underlying 25,000 Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes common stock and the number of shares of common stock underlying CDIs.

F4 · balance_after: Includes 703 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:43 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,460 $0.00 Strike: $8.19 $0.00
Disclosure

SEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · derivative · entry 5

Wiadrowski David · CIK 0001932666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,051

Underlying: Common stock · 7,460 shares

Expires 2028-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person exercised the stock options on a cashless basis.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:43 UTC Exercise / conversionStock Option (right to buy) · Derivative 13,850 $0.00 Strike: $13.35 $0.00
Disclosure

SEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · derivative · entry 4

Wiadrowski David · CIK 0001932666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 13,850 shares

Expires 2027-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person exercised the stock options on a cashless basis.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:43 UTC SaleCommon Stock 5,957 $41.34 $246,262.38
Disclosure

SEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · nonDerivative · entry 3

Wiadrowski David · CIK 0001932666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,679

F3 · kind: Shares of the Issuer's common stock were sold in the open market solely to cover the option exercise cost.

F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.27 to $41.455, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · balance_after: Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:43 UTC Exercise / conversionCommon Stock 7,460 $8.19 $61,097.40
Disclosure

SEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · nonDerivative · entry 2

Wiadrowski David · CIK 0001932666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person exercised the stock options on a cashless basis.

F2 · balance_after: Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:43 UTC Exercise / conversionCommon Stock 13,850 $13.35 $184,897.50
Disclosure

SEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · nonDerivative · entry 1

Wiadrowski David · CIK 0001932666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person exercised the stock options on a cashless basis.

F2 · balance_after: Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:34 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-26-000031 · wk-form4_1773779682.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,440

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:34 UTC SaleCommon stock 7,930 $41.40 $328,302.00
Disclosure

SEC source: 0001581760-26-000031 · wk-form4_1773779682.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:34 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-26-000031 · wk-form4_1773779682.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:27 UTC SaleCommon stock 2,758 $46.56 $128,412.48
Disclosure

SEC source: 0001581760-26-000029 · wk-form4_1773260842.xml · nonDerivative · entry 2

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 5,065

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.95 to $46.85, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:27 UTC SaleCommon stock 1,242 $45.29 $56,250.18
Disclosure

SEC source: 0001581760-26-000029 · wk-form4_1773260842.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 7,823

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.75 to $45.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 21:34 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 17,153 $44.86 $769,483.58
Disclosure

SEC source: 0001581760-26-000023 · wk-form4_1773178494.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,232

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 143,367 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 21:38 UTC
Hulls ChrisDirector
Tax withholdingCommon Stock 5,248 $44.91 $235,687.68
Disclosure

SEC source: 0001581760-26-000025 · wk-form4_1773178712.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,452

F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 21:40 UTC
Burke Russell JohnChief Financial Officer
Tax withholdingCommon stock 5,800 $44.91 $260,478.00
Disclosure

SEC source: 0001581760-26-000027 · wk-form4_1773178803.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,857

F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

F2 · balance_after: Includes 56,573 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 21:54 UTC Exercise / conversionStock Option (right to buy) · Derivative 31,938 $0.00 Strike: $0.18 $0.00
Disclosure

SEC source: 0001581760-26-000021 · wk-form4_1773093260.xml · derivative · entry 4

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 31,938 shares

Expires 2026-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 21:54 UTC Exercise / conversionCommon stock 31,938 $0.18 $5,748.84
Disclosure

SEC source: 0001581760-26-000021 · wk-form4_1773093260.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,202

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F2 · balance_after: These numbers have been adjusted to reflect that the transfer of 1,672 directly held shares to the John Coghlan Living Trust, which was inadvertently reported in the Form 4 filed December 16, 2025, has not yet occurred.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 21:18 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-26-000008 · wk-form4_1771449482.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,370

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 21:18 UTC SaleCommon stock 7,930 $49.02 $388,728.60
Disclosure

SEC source: 0001581760-26-000008 · wk-form4_1771449482.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 21:18 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-26-000008 · wk-form4_1771449482.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
January 14, 2026 Filed Jan 17, 2026 00:07 UTC
Burke Russell JohnChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 12,427 $0.00 Strike: $3.58 $0.00
Disclosure

SEC source: 0001581760-26-000004 · wk-form4_1768608419.xml · derivative · entry 3

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 419,087

Underlying: Common stock · 12,427 shares

Expires 2030-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This stock option is fully vested and exercisable.

Read SEC document
January 14, 2026 Filed Jan 17, 2026 00:07 UTC
Burke Russell JohnChief Financial Officer
Exercise / conversionCommon stock 12,427 $3.58 $44,488.66
Disclosure

SEC source: 0001581760-26-000004 · wk-form4_1768608419.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The Reporting Person transferred 18,524 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 72,230 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
January 13, 2026 Filed Jan 15, 2026 22:01 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-26-000002 · wk-form4_1768514489.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,300

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
January 13, 2026 Filed Jan 15, 2026 22:01 UTC SaleCommon stock 7,930 $61.98 $491,501.40
Disclosure

SEC source: 0001581760-26-000002 · wk-form4_1768514489.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
January 13, 2026 Filed Jan 15, 2026 22:01 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-26-000002 · wk-form4_1768514489.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 01:32 UTC
Hulls ChrisDirector
SaleCommon Stock 707 $64.49 $45,594.43
Disclosure

SEC source: 0000905148-25-004433 · form4.xml · nonDerivative · entry 2

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by ICCA Labs, LLC

Disclosed balance after: 0

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 01:32 UTC
Hulls ChrisDirector
SaleCommon Stock 1,139 $63.63 $72,474.57
Disclosure

SEC source: 0000905148-25-004433 · form4.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by ICCA Labs, LLC

Disclosed balance after: 707

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 01:32 UTC
Haro AlexDirector
SaleCommon Stock 722 $64.49 $46,561.78
Disclosure

SEC source: 0000905148-25-004432 · form4.xml · nonDerivative · entry 2

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by ICCA Labs, LLC

Disclosed balance after: 0

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 01:32 UTC
Haro AlexDirector
SaleCommon Stock 1,165 $63.63 $74,128.95
Disclosure

SEC source: 0000905148-25-004432 · form4.xml · nonDerivative · entry 1

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by ICCA Labs, LLC

Disclosed balance after: 722

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 01:32 UTC
Synge JamesDirector
SaleCommon Stock 1,518 $64.49 $97,895.82
Disclosure

SEC source: 0000905148-25-004431 · form4.xml · nonDerivative · entry 2

Synge James · CIK 0001932661 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by ICCA Labs, LLC

Disclosed balance after: 0

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 01:32 UTC
Synge JamesDirector
SaleCommon Stock 2,448 $63.63 $155,766.24
Disclosure

SEC source: 0000905148-25-004431 · form4.xml · nonDerivative · entry 1

Synge James · CIK 0001932661 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by ICCA Labs, LLC

Disclosed balance after: 1,518

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 23:11 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-25-000245 · wk-form4_1766013110.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,230

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 23:11 UTC SaleCommon stock 7,930 $68.30 $541,619.00
Disclosure

SEC source: 0001581760-25-000245 · wk-form4_1766013110.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 23:11 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-25-000245 · wk-form4_1766013110.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 22:34 UTC
Burke Russell JohnChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $3.58 $0.00
Disclosure

SEC source: 0001581760-25-000243 · wk-form4_1766010874.xml · derivative · entry 3

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 431,514

Underlying: Common stock · 2,500 shares

Expires 2030-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This stock option is fully vested and exercisable.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 22:34 UTC
Burke Russell JohnChief Financial Officer
Exercise / conversionCommon stock 2,500 $3.58 $8,950.00
Disclosure

SEC source: 0001581760-25-000243 · wk-form4_1766010874.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 72,230 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 21:10 UTC Exercise / conversionStock Option (right to buy) · Derivative 920 $0.00 Strike: $2.15 $0.00
Disclosure

SEC source: 0001581760-25-000241 · wk-form4_1765919405.xml · derivative · entry 4

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,306

Underlying: Common stock · 920 shares

Expires 2027-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 21:10 UTC Exercise / conversionCommon stock 920 $2.15 $1,978.00
Disclosure

SEC source: 0001581760-25-000241 · wk-form4_1765919405.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The Reporting Person transferred 1,672 directly held shares to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 09, 2025 Filed Dec 10, 2025 01:47 UTC GiftCommon Stock 3,045 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004289 · form4.xml · nonDerivative · entry 3

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 9,065

F5 · kind: This transaction reflects a bona fide gift of the Issuer's common stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.

Read SEC document
December 05, 2025 Filed Dec 10, 2025 01:47 UTC SaleCommon Stock 1,100 $77.96 $85,756.00
Disclosure

SEC source: 0000905148-25-004289 · form4.xml · nonDerivative · entry 2

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 12,110

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $77.52 to $78.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.